Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,214 total articles
Greenland Mines Ltd has commenced its 2026 field season at the Skaergaard Project with a large, multifaceted exploration and development program. The comprehensive season includes drilling, bulk sampling, geophysical surveys, environmental monitoring, and engineering studies aimed at upgrading the mineral resource and progressing toward an initial …
Luda Technology Group Limited announced a sales blanket agreement worth approximately RMB1.6 billion with Shandong Yulong Petrochemical to supply pipeline fittings for the Yulong Island Refining and Chemical Integration Project (Phase One). Building on a previous contract for stainless steel flanges for the same project, this agreement underscores …
Bit Origin Ltd outlined its key priorities for fiscal 2027, emphasizing the deployment of sixteen NVIDIA Blackwell B300 AI servers as part of its AI computing infrastructure expansion. The company proposed rebranding to SANGRIX to align with its next phase of growth centered on AI computing and digital infrastructure. The name change requires share…
East West Ave Acquisition Corp., a U.S.-based blank check company, has priced its initial public offering (IPO) of 10 million units at $10 each, totaling $100 million. The units will begin trading on Nasdaq under the symbol EWAVU, with the component common stock and rights separately trading as EWAV and EWAVR, respectively. The company intends to u…
NewcelX Ltd., a clinical-stage biopharmaceutical company focused on stem cell-based therapies for type 1 diabetes, announced a private placement financing of $1.4 million priced at a 20% premium to its recent closing share price. The funding, including warrants, will be used primarily to advance NCEL-101 towards IND-enabling studies, in collaborati…
Steakholder Foods Ltd., a Nasdaq-listed company specializing in 3D-printed plant-based meats, announced a private placement raising $3.5 million upfront with potential for an additional $7 million through warrants. The proceeds will fund research, development, and growth initiatives, including the upcoming U.S. launch of their Perfecta™ Premium Pla…
The XAI Madison Equity Premium Income Fund (MCN) has adjourned its Special Meeting of Shareholders due to a lack of quorum and will reconvene on August 26, 2026. Shareholders are encouraged to vote on the proposal to approve a new sub-advisory agreement, which the Fund's Board recommends.
Nuwellis, Inc., a medical technology firm focused on cardiorenal solutions, announced it entered into a securities purchase agreement to sell approximately 1.31 million shares of common stock at $2.59 per share in an at-the-market registered direct offering under Nasdaq rules, raising $3.4 million. Concurrently, the company received $3.1 million fr…
Netcapital Inc. reports that the SEC has stayed the recently approved Nasdaq rule requiring companies with market value of listed securities (MVLS) below $5 million to face immediate delisting. The full SEC Commission will review the rule, currently suspended, providing Netcapital and other small-cap Nasdaq companies more time to focus on turnaroun…
Trading in Jiade Limited's Class A Ordinary Shares, which had been halted on June 4, 2026, resumed on July 31, 2026 at 12:00 p.m. Eastern Time on the Nasdaq stock exchange. The announcement comes directly from Nasdaq with no specific reasons or additional details provided about the resumption or prior trading halt.
Achieve Life Sciences, a late-stage specialty pharmaceutical company focused on cytisinicline for nicotine dependence, announced stock option and restricted stock unit grants to six new employees under its 2024 Equity Inducement Plan. These grants aim to attract key talent to support the company's ongoing development and commercialization efforts. …
NOMAD Power Solutions, a leader in transportable battery energy storage systems, announced that its common stock is now available for options trading on the Cboe Options Exchange under the symbol NMAD. This move is aimed at increasing visibility, liquidity, and investor participation while supporting the company's mission to deliver flexible energy…
Alliance Entertainment Holding Corporation, via its AMPED Distribution division, is orchestrating a comprehensive nationwide retail marketing campaign for Shaboozey’s new album 'The Outlaw Cherie Lee & Other Western Tales.' The campaign integrates independent record stores, major retailers, and e-commerce platforms, featuring listening parties, exc…
XAI Floating Rate & Alternative Income Trust (XFLT) is urging shareholders to vote in favor of appointing King Street Capital Management's subsidiary, Rockford Tower Asset Management, as the long-term sub-adviser. Alongside this, the Fund's Board has proposed a liquidity plan and discount management program designed to enhance shareholder value and…
Stablecoin Development Corporation, trading on the NYSE American as SDEV, disclosed its second quarter and first half 2026 financial results highlighting $2.2 million in quarterly staking revenue, a 10% holding of 2.29 billion SKY tokens, elimination of all remaining warrant liabilities, and a $50.6 million non-cash unrealized loss due to SKY price…
Plus Therapeutics, Inc. is rebranding as Cerenome, Inc., with a new Nasdaq ticker CNSY, reflecting its transformation into an integrated central nervous system (CNS) oncology company. Cerenome aims to combine precision diagnostics (CNSide®), targeted radiotherapeutics (REYOBIQ™), and proprietary data analytics powered by artificial intelligence to …
Barfresh Food Group, Inc., a Nasdaq-listed company specializing in ready-to-blend and ready-to-drink beverages for various markets including education and foodservice, will release its second quarter 2026 financial results on August 14, 2026. The company will host a conference call and webcast to discuss the results.
Vistagen Therapeutics, a late clinical-stage biopharmaceutical company specializing in intranasal neurocircuitry-focused treatments, announced the appointment of Douglas J. Williamson, MD, to its Board of Directors. Dr. Williamson brings extensive experience in neuroscience drug development and regulatory approvals, expected to strengthen Vistagen'…
Arbor Realty Trust reported a GAAP net loss of $37.3 million in Q2 2026, a decline from net income in the prior year period. Distributable earnings were $0.10 per diluted common share. The company enhanced liquidity by raising approximately $500 million via capital markets transactions, used partly for share repurchases and redeeming senior notes. …
The Nasdaq Stock Market has resumed trading of Inno Holdings Inc. (INHD) at noon on July 31, 2026, following a trading halt that began on June 8, 2026. The reason for the halt was not disclosed in the announcement. Investors can now trade the company’s shares again on Nasdaq.
EuroDry Ltd., a NASDAQ-listed drybulk shipping company, will announce its Q2 2026 financial results on August 6, 2026, before US market opens. Management will hold a conference call and webcast to discuss the report. The company operates a fleet of 11 drybulk vessels, with plans to expand to 15 vessels by 2028.
Cycurion, a Nasdaq-listed cybersecurity and AI solutions provider, has entered into a warrant inducement transaction with an institutional investor, raising approximately $4.5 million in gross proceeds through the immediate exercise of warrants. In return, the investor receives new warrants to purchase additional shares at a higher exercise price, …
SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs, announced a technological milestone for their quantum sampling workflow platform, demonstrating a complete end-to-end hybrid quantum-classical analytical process for clinical trial data analytics. This advancement supports processing high-dimensional biomedical datasets with enha…
IRADIMED CORPORATION reported Q2 2026 revenue of $20.5 million, a slight increase from Q2 2025, and earnings per share of $0.41 GAAP and $0.46 non-GAAP. The company launched its new 3870 MR IV pump with positive initial market acceptance and expects revenue and earnings growth in the back half of 2026, reaffirming full-year guidance. A quarterly ca…
Moleculin Biotech announced positive interim blinded results from Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin plus cytarabine for relapsed or refractory acute myeloid leukemia (AML). The trial showed a 37% composite complete remission rate (CRc) even in patients who failed prior venetoclax treatment, significantly outperformi…
